Stroke survivors were more likely to have little or no disability after 90 days if a clot was removed from a large brain artery followed by the injection of the clot-dissolving medication tenecteplase directly into the artery near the blockage, compared to people receiving standard medical treatment after clot removal. In this trial, standard care was clot removal without clot-dissolving medication.

The American Heart Association’s 2025 Heart Disease and Stroke Statistical Update reports that while progress has been made in reducing cardiovascular and cerebral health disparities, Black communities in the United States still  face disproportionately higher risk of heart disease, stroke and hypertension.

Neither a placebo procedure nor two different doses of transcranial brain stimulation, which send electrical signals through the skull, improved mobility recovery in stroke survivors receiving movement therapy. Motor function was similar among survivors who received electrical brain stimulation combined with movement therapy or a placebo combined with movement therapy.

The American Heart Association and the National Football League provide $1,000 financial grants to support physical activity

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 days after a stroke than standard care alone (including clot-busting medication if indicated). While researchers say using thrombectomy devices to remove blood clots is increasingly performed, this research suggests that it may not be needed in all cases.However, because endovascular therapy seemed to be safe, it might still be used on select patients.